203696 BPIQ-I
A cell-permeable, reversible, ATP-competitive, potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR; IC₅₀ = 25 pM).
More>> A cell-permeable, reversible, ATP-competitive, potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR; IC₅₀ = 25 pM). Less<<BPIQ-I MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Synonyms: 8-[(3-Bromophenyl)amino]-3-methyl-3H-imidazo[4,5-g]-quinazoline
Recommended Products
Přehled
| Replacement Information |
|---|
Tabulka spec. kláve
| CAS # | Empirical Formula |
|---|---|
| 174709-30-9 | C₁₆H₁₂BrN₅ |
| References | |
|---|---|
| References | Rewcastle, G.W., et al. 1996. J. Med. Chem. 39, 918. |
| Product Information | |
|---|---|
| CAS number | 174709-30-9 |
| ATP Competitive | Y |
| Form | Off-white solid |
| Hill Formula | C₁₆H₁₂BrN₅ |
| Chemical formula | C₁₆H₁₂BrN₅ |
| Reversible | Y |
| Structure formula Image | |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | EGFR |
| Primary Target IC<sub>50</sub> | 25 pM against tyrosine kinase activity of the epidermal growth factor receptor (EGFR) |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Katalogové číslo | GTIN |
| 203696 | 0 |
Documentation
BPIQ-I Certificates of Analysis
| Title | Lot Number |
|---|---|
| 203696 |
References
| Přehled odkazů |
|---|
| Rewcastle, G.W., et al. 1996. J. Med. Chem. 39, 918. |